Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-18

FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a generic Rizatriptan Benzoate product (ANDA 203269) from Ascend Laboratories for the acute treatment of migraine. This represents an original gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)